• Latest Posts

Sanofi’s Enjaymo for hemolytic anemia given marketing authorization by EC

Interview 14 Nov 2022

In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus

Prurigo nodularis treatment recommended for EU approval  

Positive results of cancer treatment to be presented at Boston conference

Servier and OSE Immunotherapeutics complete enrollment in Sjögren’s syndrome trial

Scancell signs agreement with Genmab

ADVERTISEMENT